Brief: Implanet Announces CFDA Approval For Its Innovative Jazz Range In China
15/07/2025 17:40
July 15 (Reuters) - Implanet SA ALIMP.PA: IMPLANET ANNOUNCES CFDA APPROVAL FOR ITS INNOVATIVE JAZZ RANGE IN CHINA Source text: ID:nBw1RqtkGa Further company coverage: ALIMP.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Implanet SA
See all newsFrench orthopedic implants maker Implanet's nine-month revenue jumps, partly on strong US momentum
French and Benelux stocks-Factors to watch on September 16
France's IMPLANET H1 revenue rises on medical equipment strength, US growth
Brief: IMPLANET H1 Revenue EUR 7.1 Million
France's IMPLANET H1 revenue rises on spine implants strength, US growth